Mislabeling Leads to Cyclobenzaprine Hydrochloride Recall

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur – © Artur – stock.adobe.com

FDA announced on Aug. 27, 2025 that Unichem Pharmaceuticals (USA) has voluntarily recalled one lot of Cyclobenzaprine Hydrochloride Tablets USP 10 mg. The recall was initiated because the Cyclobenzaprin label was placed on a bottle that contained Meloxicam 7.5 mg tablets.

While the company has not received any reports of adverse events as of the date of the recall notice, if Meloxicam is taken unknowingly, serious events could result, such as cardiovascular, gastrointestinal, renal,…